TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ADCT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -36.8% +105.3% -100.0% – +518.9% -66.9% +1.8% +14.9%
– +38.1% -8.9% +31.9% -99.0% +137.0% -23.4% +135.2% +29.0%
– – – -6,160.5% – +535.2% -67.6% -3.2% +13.6%
– +38.3% -9.1% +32.1% +11.2% +18.0% -31.8% -13.8% -5.1%
– +10.2% +65.1% +288.2% +29.6% +50.8% -32.4% -11.5% -43.3%
– +36.0% -4.2% -36.4% +279.9% +12.1% -29.4% -16.1% -6.9%
– – – – – – – – –
– +22.4% -95.2% +3,057.7% +272.3% +100.3% +26.1% +8.4% +2.8%
– – – – – – – – –
– +366.7% +159.8% -43.8% -6,668.5% – +17,127.3% -99.6% -194.6%
– – – – – – – – –
– – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?